Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall

By: via Benzinga
Spruce Biosciences Inc(NASDAQ:SPRB) shares plummeted on Thursday after the company released topline results from its CAHmelia-203 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.